Search research articles
Contact Us
Filters
Showing results (851-860 of 920) with videos related to
Page
of 92
Sort By:
Zhonghua Xin Xue Guan Bing Za Zhi
|
December 22, 2009
[Novel MYBPC3 mutations in Chinese patients with hypertrophic cardiomyopathy]
Zhan-feng Ma, Wen-ling Liu, Da-yi Hu, et al.
The Lancet. Respiratory Medicine
|
September 13, 2024
Savolitinib in patients in China with locally advanced or metastatic treatment-naive non-small-cell lung cancer harbouring MET exon 14 skipping mutations: results from a single-arm, multicohort, multicentre, open-label, phase 3b confirmatory study
Yongfeng Yu, Qisen Guo, Yongchang Zhang, et al.
Science Immunology
|
May 10, 2024
Single-cell analysis of anti-BCMA CAR T cell therapy in patients with central nervous system autoimmunity
Chuan Qin, Min Zhang, Da-Peng Mou, et al.
Hepatology International
|
July 24, 2015
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update
Yun-Fan Liaw, Jia-Horng Kao, Teerha Piratvisuth, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 25, 2021
Apatinib Plus Gefitinib as First-Line Treatment in Advanced EGFR-Mutant NSCLC: The Phase III ACTIVE Study (CTONG1706)
Hongyun Zhao, Wenxiu Yao, Xuhong Min, et al.
The Lancet Regional Health. Western Pacific
|
April 6, 2026
Efficacy and safety of savolitinib in Chinese patients with locally advanced or metastatic <i>MET</i> exon 14-mutated non-small cell lung cancer: final results of a confirmatory Phase 3b study
Yongfeng Yu, Qisen Guo, Yongchang Zhang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
March 21, 2022
Lorlatinib for Previously Treated ALK-Positive Advanced NSCLC: Primary Efficacy and Safety From a Phase 2 Study in People's Republic of China
Shun Lu, Qing Zhou, Xiaoqing Liu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 28, 2021
Sintilimab Plus Platinum and Gemcitabine as First-Line Treatment for Advanced or Metastatic Squamous NSCLC: Results From a Randomized, Double-Blind, Phase 3 Trial (ORIENT-12)
Caicun Zhou, Lin Wu, Yun Fan, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
August 10, 2024
Efficacy and Safety of KRASG12C Inhibitor IBI351 Monotherapy in Patients With Advanced NSCLC: Results From a Phase 2 Pivotal Study
Qing Zhou, Xiangjiao Meng, Longhua Sun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 28, 2018
Circulating Tumor Cells with Stem-Like Phenotypes for Diagnosis, Prognosis, and Therapeutic Response Evaluation in Hepatocellular Carcinoma
Wei Guo, Yun-Fan Sun, Min-Na Shen, et al.
Page
of 92
Search research articles
Search
Showing results (851-860 of 920) with videos related to
Sort By:
Page
of 92
Zhonghua Xin Xue Guan Bing Za Zhi
|
December 22, 2009
[Novel MYBPC3 mutations in Chinese patients with hypertrophic cardiomyopathy]
Zhan-feng Ma, Wen-ling Liu, Da-yi Hu, et al.
The Lancet. Respiratory Medicine
|
September 13, 2024
Savolitinib in patients in China with locally advanced or metastatic treatment-naive non-small-cell lung cancer harbouring MET exon 14 skipping mutations: results from a single-arm, multicohort, multicentre, open-label, phase 3b confirmatory study
Yongfeng Yu, Qisen Guo, Yongchang Zhang, et al.
Science Immunology
|
May 10, 2024
Single-cell analysis of anti-BCMA CAR T cell therapy in patients with central nervous system autoimmunity
Chuan Qin, Min Zhang, Da-Peng Mou, et al.
Hepatology International
|
July 24, 2015
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update
Yun-Fan Liaw, Jia-Horng Kao, Teerha Piratvisuth, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 25, 2021
Apatinib Plus Gefitinib as First-Line Treatment in Advanced EGFR-Mutant NSCLC: The Phase III ACTIVE Study (CTONG1706)
Hongyun Zhao, Wenxiu Yao, Xuhong Min, et al.
The Lancet Regional Health. Western Pacific
|
April 6, 2026
Efficacy and safety of savolitinib in Chinese patients with locally advanced or metastatic <i>MET</i> exon 14-mutated non-small cell lung cancer: final results of a confirmatory Phase 3b study
Yongfeng Yu, Qisen Guo, Yongchang Zhang, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
March 21, 2022
Lorlatinib for Previously Treated ALK-Positive Advanced NSCLC: Primary Efficacy and Safety From a Phase 2 Study in People's Republic of China
Shun Lu, Qing Zhou, Xiaoqing Liu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 28, 2021
Sintilimab Plus Platinum and Gemcitabine as First-Line Treatment for Advanced or Metastatic Squamous NSCLC: Results From a Randomized, Double-Blind, Phase 3 Trial (ORIENT-12)
Caicun Zhou, Lin Wu, Yun Fan, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
August 10, 2024
Efficacy and Safety of KRASG12C Inhibitor IBI351 Monotherapy in Patients With Advanced NSCLC: Results From a Phase 2 Pivotal Study
Qing Zhou, Xiangjiao Meng, Longhua Sun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 28, 2018
Circulating Tumor Cells with Stem-Like Phenotypes for Diagnosis, Prognosis, and Therapeutic Response Evaluation in Hepatocellular Carcinoma
Wei Guo, Yun-Fan Sun, Min-Na Shen, et al.
Page
of 92